Top Markets
Coin of the day
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.

Steminent Biotherapeutics Inc.

7729
Rangering i aksjer #18871
Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to... Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to pioneering novel cellular therapeutics, with a primary focus on the research and development of innovative stem cell drugs. Their flagship product is Stemchymal, which is recognized for its significant therapeutic benefits and broad range of potential applications. The firm was established on December 18, 2007, and operates from its headquarters in Taipei, Taiwan.
Aksjekurs
$2.51
Markedsverdi
$183.34M
Endring (1 dag)
0.90%
Endring (1 år)
91.17%
Land
TW
Handel Steminent Biotherapeutics Inc. (7729)

Kategori

EPS for Steminent Biotherapeutics Inc. (7729)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Steminent Biotherapeutics Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Steminent Biotherapeutics Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH